Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 9, 2004, Pages 624-634

  Shier, Luke R ^a   Schultz, Kirk R ^b   Imren, Suzan ^c   Regan, Jill ^a   Issekutz, Andrew ^a   Sadek, Irene ^a   Gilman, Andrew ^d   Luo, Zhijuan ^b   Panzarella, Tony ^e   Eaves, Connie J ^c   Couban, Stephen ^a,f  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

B cells; Bone marrow; Dendritic cells; G CSF; Immune function; Peripheral blood; Stem cells

Indexed keywords

CD123 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOTRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL CULTURE; CELL POPULATION; CELL TYPE; CHRONIC DISEASE; COLONY FORMING CELL; CONTROLLED STUDY; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; LYMPHOCYTE COUNT; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SIDE EFFECT;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW CELLS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTES; REFERENCE VALUES;

EID: 4344653920     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.05.009     Document Type: Article

References (56)

1. Bensinger W.I. Martin P.J. Storer B. et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematological cancers N Engl J Med. 344 2001 175-181
2. Blaise D. Kuentz M. Fortanier C. et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle J Clin Oncol. 18 2000 537-546
3. Couban S. Simpson D.R. Barnett M.J. et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies Blood 100 2002 1525-1531
4. Schmitz N. Beksac M. Hasenclever D. et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia Blood 100 2002 761-767
5. Watanabe T. Takaue Y. Kawano Y. et al. HLA-identicall sibling peripheral blood stem cell transplantation in children and adolescents Biol Blood Marrow Transplant 8 2002 26-31
6. Ringden O. Labopin M. Bacigalupo A. et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia J Clin Oncol. 20 2002 4655-4664
7. Eapen M. Klein J.P. Champlin R.E. et al. Increased chronic graft versus host disease and mortality after peripheral blood stem cell transplantation in older children and adolescents with acute leukemia Blood 100 2002 545a (abstr.).
8. Couban S. Barnett M. The source of cells for allografting Biol Blood Marrow Transplant 9 2003 669-673
9. Cutler C. Giri S. Jeyapalan S. et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis J Clin Oncol. 19 2001 3685-3691
10. Couban S. Messner H.A. Andreou P. et al. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients Biol Blood Marrow Transplant 6 2000 422-427
11. Ji S.Q. Chen H.R. Wang H.X. et al. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia Biol Blood Marrow Transplant 8 2002 261-267
12. Isola L. Scigliano E. Fruchtman S. Long-term follow-up after allogeneic granulocyte colony-stimulating factor-primed bone marrow transplantation Biol Blood Marrow Transplant 6 2000 428-433
13. Serody J.S. Sparks S.D. Lin Y. et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation Biol Blood Marrow Transplant 6 2000 434-440
14. Morton J. Hutchins C. Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells Blood 98 2001 3186-3191
15. Arpinati M. Green C.L. Heimfeld S. et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood 95 2000 2484-2490
16. Klangsinsirikul P. Russell N.H. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells Exp Hematol. 30 2002 495-501
17. Zaucha J.M. Gooley T. Bensinger W.I. et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation Blood 98 2001 3221-3227
18. Franzke A. Piao W. Lauber J. et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases Blood 102 2003 734-739
19. To L.B. Haylock D.N. Simmons P.J. et al. The biology and clinical uses of blood stem cells Blood 89 1997 2233-2258
20. van der Loo J.C. Hanenberg H. Cooper R.J. et al. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells Blood 92 1998 2556-2570
21. Korbling M. Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 98 2001 2900-2908
22. Glimm H. Eisterer W. Lee K. et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice J Clin Invest. 107 2001 199-206
23. Dicke K.A. Hood D.L. Arneson M. et al. Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting Exp Hematol. 25 1997 34-38
24. Isola L.M. Scigliano E. Skerrett D. et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF Bone Marrow Transplant 20 1997 1033-1037
25. Chiang K.Y. Lamb L. Clark J. et al. Assessment of G-CSF stimulated BM hematopoietic stem cells in normal donors Cytotherapy 4 2002 55-63
26. Dahl E. Burroughs J. DeFor T. et al. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood Bone Marrow Transplant 32 2003 575-580
27. + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering J Hematother. 5 1996 213-216
28. Schultz K.R. Su W.N. Hsiao C.C. et al. Chloroquine prevention of murine MHC-disparate acute graft-versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterations in T-cell cytokine production Biol Blood Marrow Transplant 8 2002 648-655
29. Hogge D.E. Lansdorp P.M. Reid D. et al. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor Blood 88 1996 3765-3773
30. - cells stimulated by multiple growth factors in vitro Blood 94 1999 1926-1932
31. Verlinden S.F. van Es H.H. van Bekkum D.W. Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice Exp Hematol. 26 1998 627-630
32. Lapidot T. Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells Exp Hematol. 30 2002 973-981
33. Korbling M. Effects of granulocyte colony-stimulating factor in healthy subjects Curr Opin Hematol. 5 1998 209-214
34. Korbling M. Huh Y.O. Durett A. et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease Blood 86 1995 2842-2848
35. Fujisaki T. Otsuka T. Harada M. et al. Granulocyte colony-stimulating factor mobilizes primitive hematopoietic stem cells in normal individuals Bone Marrow Transplant 16 1995 57-62
36. Prosper F. Stroncek D. Verfaillie C.M. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor Blood 88 1996 2033-2042
37. Shustov A. Luzina I. Nguyen P. et al. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity J Clin Invest. 106 2000 R39-R47
38. Storek J. Wells D. Dawson M.A. et al. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation Blood 98 2001 489-491
39. Kerre T.C. De Smet G. De Smedt M. et al. Both CD34+38+ and CD34+38- cells home specifically to the bone marrow of NOD/LtSZ scid/scid mice but show different kinetics in expansion J Immunol. 167 2001 3692-3698
40. Hogan C.J. Shpall E.J. Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice Proc Natl Acad Sci U S A. 99 2002 413-418
41. Schultz K.R. Paquet J. Bader S. et al. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease Bone Marrow Transplant 16 1995 289-295
42. Ratanatharathorn V. Ayash L. Reynolds C. et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody Biol Blood Marrow Transplant 9 2003 505-511
43. Ratanatharathorn V. Carson E. Reynolds C. et al. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease Ann Intern Med. 133 2000 275-279
44. Miklos D.B. Kim H.T. Zorn E. et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors Blood 103 2004 353-359
45. Zorn E. Miklos D.B. Floyd B.H. et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation J Exp Med. 199 2004 1133-1142
46. Soulas P. Koenig-Marrony S. Julien S. et al. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells Eur J Immunol. 32 2002 2623-2634
47. Arpinati M. Chirumbolo G. Urbini B. et al. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation Transpl Immunol. 11 2003 345-356
48. Schots R. Kaufman L .Van Riet I. et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation Leukemia 17 2003 1150-1156
49. Clark F.J. Freeman L. Dzionek A. et al. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease Transplantation 75 2003 221-225
50. Gorgun G. Miller K.B. Foss F.M. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease Blood 100 2002 941-947
51. Waller E.K. Rosenthal H. Sagar L. DC2 effect on survival following allogeneic bone marrow transplantation Oncology (Huntingt) 16 1 suppl 1 2002 19-26
52. Chan G.W. Gorgun G. Miller K.B. et al. Persistence of host dendritic cells after transplantation is associated with graft versus host disease Biol Blood Marrow Transplant 9 2003 170-176
53. Kadowaki N. Ho S. Antonenko S. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens J Exp Med. 194 2001 863-869
54. Iho S. Type I IFN synthesis in plasmacytoid dendritic cells J Immunol. 171 2003 2767
55. De Wit D. Olislagers V. Goriely S. et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns Blood 103 2004 1030-1032
56. Poeck H. Wagner M. Battiany J. et al. Plasmacytoid dendritic cells, antigen and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T cell help Blood 103 2004 3058-3064